subscribeSubscribe
Enforcement Report - Week of November 29, 2023

Enforcement Report - Week of November 29, 2023
FDA
29 Nov 2023
Share Share
NAYZILAM Results Published in `Epilepsy & Behavior`

NAYZILAM Results Published in `Epilepsy & Behavior`
PR NEWSWIRE
31 Oct 2023
Share Share
Exela recalls 3 separate drugs over particulate concerns

Exela recalls 3 separate drugs over particulate concerns
Fraiser Kansteiner FIERCE PHARMA
27 Oct 2023
Share Share
Enforcement Report - Week of June 7, 2023

Enforcement Report - Week of June 7, 2023
FDA
07 Jun 2023
Share Share
Neuraxpharm completes its presence in Benelux by opening an affiliate

Neuraxpharm completes its presence in Benelux by opening an affiliate
PR NEWSWIRE
24 Jan 2023
Share Share
Melt Pharmaceuticals’ MELT-300 Achieves Primary Sedation Endpoint

Melt Pharmaceuticals’ MELT-300 Achieves Primary Sedation Endpoint
BUSINESSWIRE
21 Dec 2022
Share Share
Cipla`s Generic Midazolam Receives Approval in the U.S.

Cipla`s Generic Midazolam Receives Approval in the U.S.
FDA
01 Nov 2022
Share Share
Rafa Receives FDA Approval For Life-saving Midazolam Autoinjector

Rafa Receives FDA Approval For Life-saving Midazolam Autoinjector
PRNEWSWIRE
30 Aug 2022
Share Share
CROSSJECT: Agreement with BARDA on ZENEO® Midazolam

CROSSJECT: Agreement with BARDA on ZENEO® Midazolam
GLOBENEWSWIRE
18 Jun 2022
Share Share
Enforcement Report - Week of January 5, 2022

Enforcement Report - Week of January 5, 2022
FDA
05 Jan 2022
Share Share